🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 11 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/12/2020 173,25 176,25 170,01 171,82 -1,34% 3,60% 492.300
28/12/2020 175,76 180,41 173,75 174,15 -0,50% 3,79% 546.600
24/12/2020 178,38 178,38 174,00 175,03 -1,70% 2,46% 220.200
23/12/2020 178,14 178,23 173,41 178,06 -0,38% 2,71% 792.500
22/12/2020 177,66 181,83 175,66 178,74 +0,97% 3,47% 798.100
21/12/2020 172,50 178,79 171,01 177,02 +0,92% 4,51% 643.200
18/12/2020 172,43 175,91 170,73 175,40 +2,54% 3,00% 1.227.000
17/12/2020 171,47 171,47 165,15 171,06 +0,55% 3,69% 980.600
16/12/2020 168,15 171,43 165,07 170,12 +1,29% 3,78% 806.400
15/12/2020 171,01 172,98 165,25 167,95 -0,94% 4,52% 693.800
14/12/2020 170,99 178,66 169,19 169,54 +1,38% 5,54% 1.628.400
11/12/2020 161,00 167,58 160,52 167,24 +4,53% 4,39% 1.400.000
10/12/2020 158,91 162,88 157,12 160,00 +0,44% 3,62% 576.000
09/12/2020 157,53 160,00 154,11 159,30 +1,59% 3,74% 559.600
08/12/2020 151,60 161,81 151,05 156,81 +3,81% 7,10% 787.500
07/12/2020 154,99 157,99 146,33 151,05 -4,48% 7,52% 1.396.600
04/12/2020 153,78 159,72 153,01 158,13 +3,13% 4,36% 690.100
03/12/2020 151,01 155,50 151,00 153,33 +2,24% 2,98% 698.100
02/12/2020 145,10 150,49 143,25 149,97 +2,76% 4,99% 615.600
01/12/2020 141,31 147,22 140,00 145,94 +3,61% 5,11% 598.100
30/11/2020 139,50 141,79 137,87 140,86 +1,23% 2,81% 579.200
27/11/2020 136,89 139,84 135,93 139,15 +2,53% 2,86% 194.900
25/11/2020 136,50 136,50 133,07 135,72 +0,45% 2,51% 254.100
24/11/2020 134,84 136,81 133,12 135,11 +0,46% 2,74% 485.000
23/11/2020 132,01 134,75 128,60 134,49 +2,52% 4,66% 415.600
20/11/2020 134,67 135,00 130,69 131,18 -2,41% 3,20% 455.300
19/11/2020 132,65 136,40 131,65 134,42 +1,29% 3,58% 591.700
18/11/2020 140,17 140,37 132,41 132,71 -5,04% 5,68% 577.100
17/11/2020 140,04 140,83 136,65 139,75 +0,04% 2,98% 530.300
16/11/2020 142,98 143,22 139,09 139,70 -1,20% 2,89% 566.600